24-PAGE SUPPLEMENT
MENDING MEDICARE Analysis and Commentary on Canada’s Health Care Crisis
A Joint Publication of the CCPA and the Canadian Health Coalition
CONTROLLING COSTS:
Canada’s single-payer system is costly — but least expensive
T
By Armine Yalnizyan
he big challenge for governments in health care is Single-payer systems set fee schedules for doctors’ services its affordability: how to pay for the things that keep and rates for hospital budget-setting. Governments, as the everyone as healthy as possible, and how to make this single biggest purchasers of service, generally get better prices level of payment politically feasible and attractive. “Social than individuals or private insurers do. The rule of thumb is marketing” of the benefits of health care is important, but in the bigger the population base, the greater the economies of the end governments’ spending power determines the degree scale, which can open the door to volume discounts. of access to health care that all citizens will enjoy. Setting fee-schedules, rates and prices in this kind of Talk of affordability is often limited to the ability to pay. context is essentially a political process. There are better But beyond their ability to pay, governments also have the and worse eras of bargaining; much depends on the relative ability to manage costs. Government decisions affect both the power of the people and groups trying to get a deal. Each public purse and individual wallets, and round of negotiations depends on the shape total health care spending in the “Single-payer systems have different parties’ points of view about economy. Public spending has greater many advantages. With just what happened in the last round of potential to control costs and extend one place to submit bills to bargaining, and the objectives for the benefits than private spending, but that new round of bargaining. Although cost and receive payment from, controls are easier to achieve through potential needs to be actively pursued. Unlike individual consumers, the system reduces duplica- single-payer systems, they are not always governments can achieve economies tion in the administration a high-priority objective. of scale, streamline administrative of different methods of payprocesses, negotiate better deals, set ment. Americans pay three Drug costs rules, assess cost-effectiveness, and times as much per person The power of single-payer systems allocate spending to where the returns could be used more effectively in our for their multiple bill-paying procurement systems, particularly in on investment are greatest. Each of these public policy levers requires thoughtful procedures.” drug programs. Prescription drugs implementation and monitoring. are the fastest-growing cost driver in health care spending, on both the public and private side. Single-payer systems The provinces all have different ways of addressing the rising Over time, Canada’s public spending on health care has costs of drugs. Their policies also influence costs for private become synonymous with the single-payer system. There insurers. The following techniques have an impact on the are many advantages of single-payer systems. With just one development and pricing of new patent drugs, as well as place to submit bills to and receive payment from, the system on the share of the generic drug industry in the market for reduces duplication in administration of different methods prescription drugs: of payment. On average, about 1.8% of Canada’s provincial • Generic substitution: All of Canada’s provincial drug and territorial costs for health care go to the structure that plans have a policy to cover only the costs of a generic pays the bills. Comparative studies show that Americans drug in place of a patent drug if they are basically, or pay, on average, three times as much per person for the chemically, the same. The effectiveness of this policy has process of paying bills for doctors’ and hospital services, been somewhat blunted by changes to patent law that primarily because there is a multiplicity of payment systems limit the use of compulsory licensing. Individuals can and each of those has its own administrative costs. Multiple opt to pay the difference between the cost of the generic insurance systems in other countries where there are large and cost of a brand-name drug. public systems, but parallel private systems for enhanced • Reference-based pricing: In a system introduced in British benefits, also drive up administrative costs. Columbia in 1995, the province controls what it will pay Beyond administrative efficiencies, single-payer systems by grouping drugs that treat the same condition and are also have a built-in advantage in their ability to negotiate better deemed to be therapeutically equivalent, whether they are deals and extend purchasing power. Canadian jurisdictions chemically the same or different. The plan limits payment have seen this advantage both used and ignored over time. (Continued on Page 14)
The CCPA Monitor
11
May 2006